Stockreport

Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq

Titan Pharmaceuticals, Inc.  (TTNP) 
NASDAQ:AMEX Investor Relations: ir.titanpharm.com
PDF NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today reported that it received a notice (the “5250 Notice”) on Novemb [Read more]